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Summary 
 
Trypanosoma brucei is the causative agent of the African sleeping sickness. Between 
mammalian hosts it is transmitted by the tsetse fly. Due to the different environments of the 
hosts the parasite has to adapt its metabolism quickly. T. brucei RNA polymerase II lacks 
transcriptional control; therefore the control of gene expression is exerted mainly at the level 
of mRNA stability and translation. RNA stability is influenced by the binding of RNA 
binding proteins (RBPs), which thereby can play a crucial role in gene expression.  
 
This work focused on the characterization of the RNA binding protein RBP10. A polyclonal 
antibody was raised which showed that RBP10 is only expressed in the BS of the parasite. A 
knockdown of RBP10 by RNAi in the bloodstream form (BS) of the parasite was lethal after 
four days. Microarray studies comparing RBP10 knockdown RNA to BS WT RNA revealed a 
widespread effect on the transcriptome with many BS-specific mRNAs decreased, including 
many mRNAs encoding proteins involved in glucose metabolism. Further, the effect of the 
inhibition of glucose uptake by phloretin treatment on the transcriptome was explored and 
compared to the effect of RBP10 RNAi.  
The ectopic expression of RBP10-myc in the PC resulted in a defect in proliferation and also 
in the expression of endogenous RBP10. Microarray studies showed that in the PC the 
artificial expression of RBP10 lead to a strong increase of many BS specific mRNAs and a 
simultaneous decrease of PC specific mRNAs. It could also be shown that the forced 
expression of RBP10 inhibited differentiation of BS to PC trypanosomes. 
Putative direct RNA targets were identified by IP with subsequent purification of bound RNA 
and deep-sequencing. However, these results do not overlap with the mRNAs affected after 
RPB10 RNAi. Also using IP probable protein interaction partners were detected revealing 
among others RBP29, which is known to be on polysomes, and PABP2. In a sucrose gradient 
RBP10 was not found in the fractions of the heavy polysomes but could be detected in 
fractions of the free proteins to the fractions of proteins in trisomes.  
These findings show that RBP10 is necessary for the expression of many BS specific 
mRNAs.  
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Zusammenfassung 
 
Trypanosoma brucei ist der Erreger der Afrikanischen Schlafkrankheit. Die Parasiten werden 
von der Tsetse Fliege zwischen den menschlichen Wirten übertragen. Deshalb ist es 
notwendig, dass sie ihren Stoffwechsel schnell an neue Umgebungen anpassen können. 
Allerdings verfügen diese Parasiten über keine transkriptionelle Kontrolle der Genexpression, 
weshalb die Kontrolle über Translation und die Stabilität der RNA sehr wichtig sind. Die 
Lebensdauer einer RNA wird bestimmt durch RNA-bindende Proteine, die daher eine 
entscheidende Rolle in der Genexpression einnehmen.  
 
In dieser Arbeit wird das RNA bindende Protein RBP10 charakterisiert. Mit Hilfe eines 
polyklonalen Antikörpers konnte gezeigt werden, dass RBP10 ausschließlich in der 
Blutstromform (BS) des Parasiten exprimiert wird und eine Reduktion der Proteinmenge für 
den Parasiten letal ist. Microarray Analysen ergaben dass RBP10 notwendig für die 
Expression vieler BS spezifischen mRNAs ist, darunter sind viele mRNAs die für Proteine 
der Glykolyse kodieren. Deshalb wurde der Effekt von Phloretin, das die Aufnahme von 
Glukose in die Zellen verhindert, ebenfalls mittels Mikroarray Analyse untersucht und mit 
den Daten der RBP10 Reduktion verglichen.  
Eine  Expression von RBP10 in Zellen im prozyklischen Stadium hatte eine Verringerung der 
Wachstumsrate zur Folge. Zudem wurden viele BS spezifische mRNAs verstärkt exprimiert. 
Eine Expression von RBP10 in BS Trypanosomen verhinderte zudem die Differenzierung in 
das prozyklische Stadium.  
Durch die Isolierung von an RBP10 gebunden RNAs und deren Sequenzierung konnten 
potentielle Ziele von RBP10 identifiziert werden. Allerdings konnte keine Übereinstimmung 
mit den Ergebnissen der Mikroarray Analyse gefunden werden. Mögliche Bindungspartner 
von RBP10 konnten mittels Massenspektroskopie ermittelt werden. Unter anderem wurde 
RBP29, welches in Polysomen gefunden wurde, wie auch PABP2 identifiziert.  
Die Ergebnisse zeigen, dass RBP10 für die Expression für viele BS spezifische mRNAs 
benötigt wird. 
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1. Introduction 
1.1 Kinetoplastids 
 
Trypanosoma brucei is an extracellular parasite which belongs to the class of Kinetoplastida. 
As seen by the analysis of the 16S rRNA, Kinetoplastids have branched early from the 
eukaryotic lineage [1]. They have developed several unique features not seen in other 
eukaryotes like the kinetoplast from which they derived their name. The kinetoplast is a 
microscopically visible structure containing the mitochondrial DNA. It is unique in terms of 
structure and replication [2], [3]. Research has focused on three different species of 
Kinetoplastida: Trypanosoma brucei, Leishmania major and Trypanosoma cruzi. T. cruzi is 
transmitted by the reduviid bug and causes the Chagas disease mainly in Mexico, Central and 
South America. Leishmania major is responsible for leishmaniasis and is transferred by the 
sandfly. Trypanosoma brucei is transmitted by the tsetse fly vector and has three subspecies: 
T. b. brucei, T. b. gambiense and T. b. rhodesiense. T. b. gambiense causes a chronic infection 
and can be found mainly in central and West Africa. For these parasites humans are thought to 
be the reservoir [4] since the infection may be unnoticed for a long time. An infection with T. 
b. rhodesiense in contrast causes a quite rapid illness and is spread in southern and east 
Africa. Here animals and livestock are thought to be the reservoir [4]. T. b. gambiense 
accounts for 95% of the reported cases of sleeping sickness. Currently there are 30,000 people 
infected (www.who.int). T. b. brucei on the other hand causes animal African trypanosomiasis 
and is not infectious for humans because it is susceptible to lysis in human blood by the 
human apolipoprotein L1 [5]. Since T. b. brucei is both not pathogenic to humans and also 
accessible to genetic manipulations it serves as a model organism for other kinetoplastids and 
is commonly studied in laboratories.  
 
1.2 Life cycle of T. brucei 
 
Trypanosomes undergo a full life cycle (Fehler! Verweisquelle konnte nicht gefunden 
werden.) when they are transmitted between humans by the tsetse fly, Glossina spp. After a 
bloodmeal of the fly from an infected person the parasites accumulate in the midgut as a 
proliferative form. Here the parasites are called procyclic trypanosomes (PC). Then they 
arrest their cell cycle and migrate to the salivary glands where they continue their replication 
as epimastigotes. At last the parasites differentiate into metacyclin trypomastigotes, which are 
non-proliferative and have adapted their surface coat to the mammalian host by expressing 
Variant Surface Glycoproteins (VSGs). Then they can be transmitted to the mammalian host 
after a bite of the fly. During their life cycle trypanosomes have to change both their 
morphology and their metabolism drastically in order to adapt to the different environments of 
their hosts. PC trypanosomes have a fully functional mitochondrion which is larger than in 
trypanosomes of the bloodstream form (BS). PC mainly utilize proline as the energy source 
[6] but are also able to use glucose if available [7]. The surface of PC trypanosomes is 
covered by acidic and proline-rich EP/GPEET proteins. These are linked to the cell surface by 
a glycosylphosphatidylinositol (GPI) anchor [8]. This protects the parasite from proteolysis in 
the midgut of the tsetse fly [9]. 
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In the BS the surface coat consists of a dense layer of VSGs. VSGs are massively expressed 
and constantly recycled [10]. Additionally, there are ~ 1000 different copies of VSG in the 
genome, from which only one is expressed from the active expression site [11]. By antigenic 
variation of the expressed VSG, trypanosomes can escape the human immune system [12] 
since the few parasites, that have 
switched the surface protein are 
not recognized by the existing 
antibodies. BS trypanosomes 
depend on the glucose of the 
host’s blood and generate all ATP 
by glycolysis. The mitochondrion 
is not fully functional in this life 
stage. As the number of parasites 
increases in the human blood the 
trypanosomes start to differentiate 
into the stumpy form. Stumpy 
parasites are non-proliferative and 
cell-cycle arrested in G1 phase 
but are prepared to be transmitted 
into the tsetse fly.  
 
 
Fig. 1: Life cycle of T. brucei, from [13].  
 
 
1.3 Differentiation of T. brucei 
 
During differentiation of BS to the PC, trypanosomes have to control their gene expression 
tightly in order to adapt to the different environments. Up to 25 % of all transcripts are 
regulated during transformation from BS to PC [14] [15] [16] [17]. The amount of mRNAs 
that are found to be regulated depends on the technique used and also on the applied 
thresholds. Some of the gene regulation that is seen during differentiation is required in order 
for the parasites to adapt to new energy sources. In the human host, the bloodstream form of 
the parasite derives its ATP from glucose catabolism by glycolysis. The glucose is taken up 
into the cell mainly by the glucose transporter THT1 [18] and utilised in the glycosomes, 
which are microbodies containing most of the glycolytic enzymes. In vitro, the differentiation 
from BS to PC can by triggered by the addition of cis-aconitate to the medium [19] and a shift 
from 37°C to 27°C; differentiation is facilitated by cis-aconitate transporters [20], and 
involves a signalling pathway that includes protein phophatases [21]. Interestingly, the 
removal of glucose alone is also sufficient for the cells to start differentiation [22] and a 
similar effect is seen after inhibition of the glucose transporter using phloretin [23]. During 
differentiation, the trypanosomes’ surface coat of variant surface glycoprotein (VSG) is 
replaced by EP and GPEET procyclins [24].  
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1.4 Gene expression in trypanosomes 
1.4.1 Transcription and splicing 
 
Trypanosomes indeed are special in the way they express their genes. Most of the mRNAs are 
transcribed by RNA-polymerase II (RNAP II), but in contrast to higher eukaryotes the search 
for promoters has been elusive so far. Furthermore transcription by RNAP II leads to very 
long polycistronic precursor RNAs including sometimes more than 100 genes which are not 
functionally clustered. Neighboring units of polycistronic transcription can be convergent or 
divergent; the region between the units is called strand switch region (SSR) [25].  Certain 
histone variants are enriched at RNAP II transcription start sites while other variants are 
enriched at transcription termination sites [26] and mark the boundaries of the transcription 
units. It seems as if transcription initiation by RNAP II would be regulated by the histone 
modifications instead by transcription factors. The transcribed precursors are subsequently 
trans-spliced into the single mRNAs, whereupon a 39 nucleotide long spliced leader RNA is 
added to the 5’ end of each mRNA. This spliced leader itself is transcribed by RNAP II and 
has a cap structure. Trans-splicing also is the preceding step for polyadenylation; these two 
reactions seem to be coupled [27], [28]. However, not all mRNAs are transcribed by RNAP 
II: The mRNAs encoding the surface proteins VSG and EP/procyclins are transcribed by the 
RNA polymerase I [29], [30]. With a few exceptions, mRNAs in trypanosomes do not contain 
introns: The gene encoding the poly-A polymerase [31] was found to have an intragenic 
region which is cis-spliced. A further search for genes containing introns revealed only a 
putative RNA helicase [32]. A characterization of the T. brucei transcriptome by RNA 
sequencing showed no additional genes harboring introns.  
 
1.4.2 RNA degradation in T. brucei 
 
The regulation of gene expression is crucial for T. brucei in order to adapt to the environments 
of the different hosts. Since transcription seems not to be regulated mRNA degradation and 
translation exert the main control over gene expression as suggest by [33], but also mRNA 
localization, mRNA export, posttranslational modification and the efficiency of trans-splicing 
could have an influence. A lot of research has focused on the degradation on mRNAs. In yeast 
and in mammalian cells, deadenylation is usually the first and rate limiting step in RNA 
decay. The degradation then can occur by two different pathways: either in the 3’ to 5’ 
direction by the exosome [34], or in the 5’ to 3’ direction by XRN1. For the 5’ to 3’ 
degradation the cap has to be removed first, which is done by the decapping enzymes Dcp2 
[35] or, in mammalian cells, also Nudt16 [36]. Trypanosomes don’t differ very much in terms 
of RNA degradation from mammalian cells: the first step in RNA degradation is 
deadenylation [37]. Then the exosome degrades RNA from the 3’ end [38]. It has an 
exonuclease and an endonuclease activity and is thought to be associated with unstable RNAs 
like EP. The alternative pathway for degradation takes place from the 5’ end, which requires a 
preceding decapping of the mRNA. However, the decapping enzymes of T.brucei have not 
yet been identified. The T. brucei genome encodes for four homologs of the 5’ to 3’ 
exoribonuclease XRN1 named XRNA, XRNB, XRNC and XRND. Only XRNA it has been 
shown to be important in mRNA degradation [39], (Manful et al, unpublished data). XRNA 
depletion also affects transcripts that are unstable or developmentally regulated as EP or 
PGKC, but also seems to have a small effect on more stable mRNAs. In mammalian cells 
RNA degradation via XRN1 is assumed to take place in cytosolic granules called P-bodies 
[40]. The presence of these structures have also been shown in trypanosomes [41], but their 
influence on mRNA degradation still needs to be investigated.   
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1.4.3 Regulation of mRNA stability by RNA binding proteins via motifs in the 3’ untranslated 
region  
 
In mammals the stability of mRNAs encoding for example for cell cycle regulators or 
cytokines is mediated by AU-rich elements in the 3’ UTR (untranslated region) of the mRNA. 
An estimated 5-8% of all human mRNAs contain AU-rich elements (ARE). Proteins that can 
bind to these elements are called ARE-BPs and have RNA binding domains like the RNA 
recognition motif (RRM), Zink finger motif or the K Homology (KH) domain. The bound 
proteins can then determine the stability of the mRNA. A well characterized protein is HuR, 
which stabilizes its target [42] [43]. HuR is an RBP containing three RRMs, which mediate 
the binding to single stranded RNA [44], [45]. Other proteins like TTP and BRF-1 [46][47] 
have a destabilizing effect on mRNAs containing an ARE sequence. 
In trypanosomes proteins bearing these RNA binding motifs are present, too. In T. brucei 75 
RNA binding proteins (RBPs) with at least one RRM have been identified [48]. The RRM 
motif contains about 90 amino acids, including the canonical RNP1 motif. In a recent in silico 
screen 48 RBPs with a Zinc finger motif have been found [49]. At least 10 RBPs with PUF-
domains were identified in T.brucei [50]. 
The sequences within the trypanosome mRNAs that mediate degradation are, at least in some 
cases, present in form of U-rich elements (URE), which are similar to AREs of mammalian 
cells. In T. cruzi the RBP UBP1 has been shown to bind to UREs of SMUG mucin mRNAs 
[51]. The binding of UBP1 is achieved by a complex formation with the RBP UBP2 and the 
Poly-A-binding protein TcPABP1 [52] and destabilizes the target. Homologues of TcUBP1 
and TcUBP2 are also expressed in T. brucei; they bind to an mRNA encoding for an F-box 
domain protein [53], although the binding to the mRNA was proposed to have little 
specificity. Also the expression of the human HuR in T. brucei had an effect: mRNAs 
containing AREs like EP and PGKB, which are normally unstable in the BS, showed an 
increase in abundance [54]. In this case the ARE is responsible for the stage-specific 
degradation of mRNAs. Previously it already had been shown by the usage of reporter 
constructs that sequences in the 3’UTR are responsible for the strong developmental 
regulation of the phosphoglycerate kinases mRNAs [55]. Also the mRNAs encoding the 
glucose transporters THT1 and THT2 are regulated by sequences in their 3’ UTR [56]. It is 
not yet known how RBPs influence the stability of their targets. It is possible that 
destabilizing RBPs could interact with the mRNA degradation machinery. Stabilizing RBPs 
could in the opposite way compete with destabilizing factors.  
Since the stabilities of mRNAs of all genes in the genome have to be regulated permanently 
due to the lack of transcriptional control, it is quite unlikely that an RBP only acts on a single 
mRNA. Rather it is probable that RBPs bind to a subset of RNAs which are regulated in the 
same manner. Indeed transcriptome analysis of differentiating cells revealed clusters of RNAs 
which are both functionally related and whose RNA abundance is changed in the same way 
[15], although they are not derived from the same precursor RNA. The mRNAs encoding 
proteins involved in glucose metabolism could be shown to be similarly regulated, together 
with the RNA binding protein RBP10. This would mean it is likely that those mRNAs may 
have similar sequences in their 3’ or 5’ UTR, but the search for motifs has not been successful 
so far. However, [57] showed that the RNA binding protein DRBD3 binds to a subset of 
developmentally regulated mRNAs encoding membrane proteins. The protein-RNA 
interaction could be narrowed down to a certain region in the 3’ UTR of the mRNA. Also in 
Leishmania the existence of two specific motifs LmSider1 and LmSider2 was shown to be 
responsible for stage-specific regulation [58]. In T. brucei Puf9, an RBP with a Puf RNA 
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binding domain, has been shown to have a stabilizing effect on mRNAs encoding for proteins 
that are cell-cycle regulated, such as LIGKA [59].  
Since RBPs seem to influence mRNAs on a large range the regulation of the RBPs themselves 
is crucial. A fast response, for example to environmental changes, can be achieved by 
posttranslational modifications like phosphorylation. In humans a well-studied protein is 
HuR: upon phosphorylation it is transported from the nucleus to the cytoplasm and stabilizes 
several target mRNAs [60]. In trypanosomes regulation of RBPs by phosphorylation is 
possible: According to [61] T. brucei has 182 predicted protein kinases which is twice as 
many as in mammalian cells in relation to percentage of the proteome. In this study the 
phosphoproteome of BS trypanosomes has been investigated. It revealed a significant number 
of phosphorylated proteins involved in DNA/RNA processing. This makes it likely that 
phosphorylation might play a role in the regulation of the activity of RBPs. For other events 
phosphorylation has already been shown to be essential: The differentiation from the BS to 
PC, which is triggered by cis-aconitate [19], is mediated by the transporter PAD1 [20] and the 
tyrosine phosphatase PTP1 [62], which regulates a second phosphatase named PIP39 [21].  
 
1.5 Glucose metabolism in BS trypanosomes 
 
BS trypanosomes rely on glucose taken up from the host’s blood to generate ATP [63]. 
Glucose is taken up by the glucose transporter THT1, whose expression is increased in the BS 
compared to the PC [64], [18]. Utilization of glucose takes place in the glycosomes, which are 
peroxisome like organelles only found in trypanosomes and related Kinetoplastida [65]. 
Glycosomes are enclosed by one phospholipid bilayer and currently it is not known how the 
glucose is transported into the organelle. In the BS more than 90% of glycosomal proteins are 
involved in glycolysis, this percentage is decreased in the PC [66, 67]. However, only the first 
seven steps of glycolysis take place in the glycosomes; the stepwise degradation of 3-
phosphoglycerate to pyruvate, which is the only end product under aerobic conditions, takes 
place in the cytosol [68]. Under anaerobic conditions a small amount of glycerol is produced 
and excreted. The last enzymatic step in the glycosome differs between BS and PC: In the BS 
the phosphoglycerate kinase PGKC is expressed, which is localized to the glycosome, while 
PC express PGKB, which is found in the cytosol. An expression of the wrong isoform is 
lethal in BS trypanosomes [69]. The control over glycolytic flux depends on the concentration 
of glucose in the blood: At the normal blood glucose concentration of 5 mM the flux control 
coefficient of the glucose transporter is between 0.3 and 0.5 [70], leaving the remaining 
control to aldolase, glyceraldehyde-3-phosphate dehydrogenase, phosphoglycerate kinase, and 
glycerol-3-phosphate dehydrogenase [71]. The flux control coefficient of the transporter 
increases with decreasing glucose concentration. Inhibition of glycolytic flux is feasible by 
either 2-deoxy-D-glucose (2-DOG) [72] or phloretin [70]. 2-DOG acts as inhibitor of glucose 
import and also on Hexokinase activity if inside the glycosome. Phloretin is not imported into 
the cell and inhibits the uptake of glucose by the transporter. It has been shown that a decrease 
of the glycolytic flux of 30 - 50% is sufficient to block growth of trypanosomes [23].  
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1.6 Aims of the thesis 
 
The objective of this thesis is the characterization of the RNA binding protein RBP10. 
Furthermore I want to assess its impact on the RNA metabolism in the cell, to identify the 
direct mRNA targets, possible protein interaction partners and investigate a possible 
phosphorylation detected by [61].  
2. Materials and Methods 
 
2.1 Trypanosome culture 
 
Except for two experiments all cells used in this study were derived from the Lister 427 strain. 
BS Trypanosomes which were kept in culture for a long time have lost the ability to undergo a 
complete differentiation and are called monomorphic. For the differentiation experiment 
(chapter 3.6) and the investigation of the effect of phloretin on RBP10 (chapter 3.7), 
EATRO1125 (clone AnTat 1.1) pleomorphic trypanosomes were used which still have the 
ability to undergo complete differentiation. All BS are kept in modified HMI9 medium [73] at 
37°C, PC in MEM [74] at 27°C. For stable transfections 2x107 cells were transfected by 
electroporation with 10-12 µg of Not1 linearized plasmid. After addition of the drug the cells 
were diluted to obtain single clones. Antibiotics were used in the following concentrations: 
phleomycin 0.2 µg/ml (BS) and 0.5 µg/ml (PC); hygromycin B 10 µg/ml (BS) and 50 µg/ml 
(PC). The induction of RNAi or overexpression of a protein was started 24 h before the cells 
were collected using 100 ng/ml tetracycline. During proliferation assays cells were diluted 
every day to 2x105 cells / ml. For differentiation assays pleomorphic cells were used. 24 h 
before beginning the differentiation the overexpression of RBP10 was induced. At t0 h cells 
were at a density of 1.5x106 cells / ml or higher. Then 6 mM cis-aconitate was added and cells 
were shifted to 27°C. At t24 h cells were centrifuged at 2000 g for 10 min and suspended in 
preheated MEM medium without tetracycline or cis-aconitate.  
 
2.2 Inhibition of glucose uptake 
 
Phloretin was purchased from Sigma. It was dissolved in 70% ethanol and added in a 
concentration of 100 µM to cells at a density of approximately 5x105 cells / ml. This resulted 
in a slow but reproducible growth to ~8x105 cells / ml in 24 h.  
 
2.3 Cell fractionation, Western blotting and immunofluorescence 
 
Cell fractionation was performed as described in [75]. For standard Western blot analysis 
3x106 cells were harvested by centrifugation at 2000 g for 10 min, washed with 1ml PBS and 
suspended in 13 µl 2x protein loading buffer. Western blots were probed with RBP10 
antibody (1:500, α rat), EP repeat (Cedar Lane, 1:2000, α mouse), XRND (1:1000, α rabbit), 
V5 (1:1000, α mouse) and Tubulin (1:2000, α mouse). Immunofluorescence was done as 
described in [75]. Additionally z-stacks with a distance of 0.14 µm were taken for 3d-
deconvolution using the wiener filter. 
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2.4 Pulse labeling with 35S-methionine 
 
2 x 106 BS cells were grown to a density of ~5x105 cells /ml, centrifuged and suspended in 
400 µl labeling medium. After one hour 125 µCi of [35S]-methionine35S was added and was 
incorporated into newly synthesized proteins for one hour. Then cells were washed twice in 
PBS, lysed in 20 µl protein loading buffer and run on a SDS gel. Afterwards the gel was fixed 
for 45 min in a mix of 10% acidic acid, 30% methanol and 60% H2O and incubated in 
en3hance solution (Perkin Elmer) for 45 min. The gel was washed with H2O and dried for 3 
hours at 65 °C. The gel then was exposed to an x-ray film at -80 °C.   
 
2.5 RNA preparation and Nothern blotting 
 
RNA was prepared from cells not exceeding 1.5 x 106 cells/ml (BS) or 2 x 106 cells/ml (PC). 
Cells were harvested and either suspended in PeqGold Trifast (Peqlab) or the RNA was 
extracted using the RNeasy mini kit (Qiagen). For Nothern blot analysis 10 µg of total RNA 
were separated by formaldehyde gel electrophoresis as described in [59], blotted onto a nylon 
membrane (GE Healthcare) and hybridized with α-[32P] radioactive DNA probes (Prime-IT 
RmT Random Primer Labelling Kit, Stratagene), which were made according to 
manufacturer’s protocol. The signals were measured with a phosphoimager and normalized to 
the signal of the 7SL probe (signal recognition particle RNA).   
 
2.6 Microarray analysis 
 
cDNA synthesis and slide hybridisations were performed as described in [15] with the 
following changes: 12 µg of total RNA were used per hybridisation; the cDNA synthesis was 
performed with 400 U RevertAid™ H Minus Reverse Transcriptase (Fermentas), the 
appropriate reaction buffer and 40 U Ribolock (Fermentas). The reaction was incubated for 2 
hours at 43 °C. DNAse treatment, cDNA purification and scanning of the slides were done as 
in [15]. The microarray slides (version 3 of Trypanosoma brucei) were obtained from the 
Pathogen Functional Genomics Resource Center – J. Craig Venter Institute. 
 
Data analysis was done using ExpressConverter and MIDAS software (freely available at 
http://www.tm4.org). Files obtained from the scan were background-substracted and 
transformed into .mev – files using ExpressConverter. Using MIDAS the signal intensities 
were normalized by locally weighted linear regression and duplicate spots on each slide were 
merged. Log2 transformed data were exported to SAM as described [76]. All RNAs with a 
change of 1.5 fold or higher and a p-value of ≤ 0.5 were considered to be significantly 
regulated. 
 
2.7 Immunoprecipitation (IP) 
 
4 x108 BS cells expressing RBP10-myc were harvested with a maximal density of 1.5 x106 
cells/ml. The same amount of BS WT cells was used as control. The cells were lysed in 1ml 
lysis buffer consisting of 10 mM NaCl, 10 mM TRIS pH 7.5, 0.1% Igepal and 1 Complete 
Inhibitor (Roche; 1 minitablet was dissolved in 7 ml buffer). Cell debris was pelleted at 
17.000g for 20 min and supernatant was adjusted to 100 mM NaCl. 50 µl of myc-agarose 
beads (Sigma) were added and incubated for 90 minutes. Afterwards the beads were washed 
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4x 10 min in lysis buffer adjusted to 100 mM NaCl. Then 30 µl of NaCl adjusted lysis buffer 
and 30 µl protein loading buffer were added and the samples boiled for 5 min.  
2.8 RNA – IP 
 
4x108 cells expressing RBP10- myc were grown to a density of 1.2 x106 cells/ml, washed 
once in ice-cold PBS, UV crosslinked with 400 mJ and a wavelength of 254 nm, centrifuged 
again and snap-frozen. All following steps were carried out at 4°C or on ice. Cells were lysed 
in 400 µl lysis buffer containing 10 mM NaCl, 10 mM TRIS pH 7.5, 0.1% Igepal, 8 mM 
Ribonucleoside-Vanadyl Complexes and 1000 U RNasin (Promega). Cell debris was pelleted 
at 17.000 g and supernatant was adjusted to 150 mM NaCl. 50 µl of myc-agarose beads 
(Sigma) were added, and incubated for one hour. Afterwards beads were separated by 
centrifugation and washed three times with cold PBS. Proteinase K (Sigma) was added and 
degradation of proteins occurred at room temperature for 15 min. Then RNA was extracted 
using the Trifast FL (Peqlab) according to manufacturer’s protocol.  
 
2.9 Expression of recombinant RBP10 for polyclonal antibody 
 
Full length open reading frame (ORF) of RBP10 (Tb927.8.2780) was cloned into the vector 
pQE-38 (Qiagen). The resultant plasmid pHD1990 was used for transformation of the E. coli 
strain BL21(DE3)pLysS (Stratagene). Bacteria were grown to OD600 of 0.6 and induced with 
1 mM isopropyl - β - D – thiogalactopyranoside for two hours at 37°C. The recombinant 
protein was purified using Ni-NTA agarose (Qiagen) according to the manufacturer’s protocol 
(Qiagen expressionist) for purification under denaturing conditions. RBP10-HIS was eluted 
once with pH 5.9 and four times with pH 4.5 (Fig. 2.1). The “elution 2 pH 4.5”, in total 2 mg, 
was dialyzed against 1xPBS at 4°C over night and sent to Charles River Laboratories for 
inoculation of a rat.  
 
 
Fig. 2: Purification of recombinant HIS-tagged RBP10 under denatured conditions.  
The obtained serum recognized both the recombinant protein and the endogenous RBP10 of 
T. brucei with a dilution of 1: 500 in 5% (W/V) milk powder in PBS-T (Fig. 4 and Fig. 19) 
 
  
  2. Materials and Methods 
 
11 
 
2.10 Dephosphorylation assay 
 
The dephosphorylation was performed with lambda phosphatase and the respective buffers 
from New England Biolabs (NEB). All steps were carried out at 4°C or on ice. 2x107 BS cells 
were lysed in 47 µl lysis buffer (50 mM TRIS, 50 mM NaCl, 2 mM MgCl2 and 0.1% Igepal). 
For 7 ml of lysis buffer 1 minitablet of complete protease inhibitor (Roche) was added. Cells 
were centrifuged for 10 min with 17.000g, and then the supernatant was transferred to a new 
tube. Afterwards 6 µl 10x reaction buffer (NEB), 6 µl MnCl2 (NEB) and 1 µl lambda 
phosphatase were added and incubated on ice for 20 min. Reaction was terminated by the 
addition of 60 µl protein loading dye and heating to 95°C prior to separation of proteins by 
SDS-PAGE. 
 
2.11 Used plasmids and primers 
 
Primers and Plasmids used in this thesis are listed in Table 1and Table 2, respectively.  
Table 1: Primers used for cloning the vectors listed in table 2.   
 
Table 2: Properties of the cloned vectors
 
The plasmids pHD 2104-2108 are cloned using site directed mutagenesis. The mutations were 
introduced using the specified primers, the second primer pair was cz4110 and cz3389.  
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3. Results 
3.1 Expression of RBP10 in BS 
 
RBP10 was found in the T. brucei genome in a screen for proteins with the RRM motif [48]. 
RBP10 is a protein of 32 kDa with one RRM from amino acid 49 to 121 close to its C-
terminus. I found that RNAi against RBP10 was lethal in the BS of the parasite while no 
effect of its depletion could be seen in the PC [77]. In this screen the vector for RNAi had two 
opposing T7- promoters. Since cell lines transfected with these vectors tend to show unstable 
RNAi phenotypes I cloned an RNAi vector for an inducible expression of an RNA stemloop, 
which is generally a more stable system. A 400bp fragment from the ORF of RBP10, which 
was blasted against the T. brucei genome to ensure the absence of off-target effects, was 
amplified by PCR and cloned into pHD 1146. The resulting vector was transfected into BS 
1313 cells, which constitutively express the tet repressor protein. The BS 1313 cell line will 
be referred to as BS WT in the subsequent text. Positively transfected clones were selected 
using hygromycin B. The knockdown of RBP10 was induced with 100 ng/ml tetracycline. 
The decrease of RBP10 was monitored by Northern blot analysis and, when the antibody 
against RBP10 was available, the depletion of the protein was measured by Western blot. The 
decrease of RBP10 is shown in Fig. 3, for the loading control the rRNA levels are displayed. 
The mRNA of RBP10 has a length of approximately 9kb due to its very long 3’UTR.  
Fortunately the uninduced RNAi sample does not show a reduction of RBP10; the cell line 
could be maintained in culture without an unintended induction of RNAi. 
 
Fig. 3: Northern blot showing the RNAi against RBP10 in the BS. The staining of the rRNA serves as loading control. 
 
The depletion of the protein can be seen in Fig. 4. RBP10 is almost completely removed after 
24 h of RBP10 RNAi while in the BS WT it can easily be detected at the expected size of ~32 
kDa. Interestingly RBP10 protein was not expressed in the PC WT in a detectable amount, 
which could explain the ineffectiveness of RBP10 RNAi in the PC seen in [77]. However, 
attempts to knock out the RBP10 gene in PC were not successful (work done by B. Seliger). 
This could either be due to technical problems or could indicate a residual function of the 
protein in the PC.  
 
 
Fig. 4: Western blot probed with RBP10 antibody showing the expression of RBP10 in BS WT, BS RBP10 RNAi and PC 
WT. 
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The knockdown of RBP10 in the BS had a strong effect on proliferation of the parasite (Fig. 
5). A decline in growth could be seen after the second day, two days later the RNAi induced 
cells were dead.   
 
 
Fig. 5: Cumulative growth curve of BS RBP10 RNAi +/- tetracycline. Open circles - tet, filled circles + tet. The cells were 
diluted to 2x105 cells/ml every day. 
 
3.2 Localization of RBP10 
 
To investigate in which step of RNA metabolism RBP10 could be involved in, the 
localization of the protein was important. Two different approaches were used to address this 
question. First, subcellular fractionation was done (Fig. 6) and showed RBP10, which has 
been myc-tagged at its C-terminus, in the cytosolic fraction. XRND, which is known to be 
localized to the nucleus, served as control [39]. For immunofluorescence the TAP-tagged 
RBP10 was used because two cross-reactions precluded us from using the RBP10 antibody. 
Attempts at purification to purify the antibody failed. RBP10-TAP was detected with the 
protein A antibody (Fig. 7), BS WT cells served as control. Here RBP10 could also be seen 
excluded from the nucleus and in distinct particles in the cytosol. 
 
Fig. 6: Western blot showing subcellular cell fractionation probed with myc and XRND antibody in BS trypanosomes. 
XRND serves as a nuclear marker protein. 
 
 
Fig. 7: Immunofluorescence against RBP10 TAP in BS using Protein A Antibody for the detection of RBP10-TAP and DAPI 
for staining the DNA. Z-stacks were taken and deconvolution was done using the wiener filter. 
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3.3 Effect of RBP10 on translation  
 
Since RBP10 is localized to the cytosol it was possible that the protein acts as a factor 
required for global translation. To investigate whether this is the case I performed a pulse-
labelling assay using 35S- methionine. Exponentially growing cells were removed from the 
medium and put into labelling medium for one hour. Afterwards they were suspended in 
medium containing the 35S methionine which would then be incorporated into newly 
synthesized proteins. The knockdown of RBP10 was induced 24 hours before. The uninduced 
RBP10 RNAi strain served as negative control. Fig. 8 shows that after RBP10 RNAi the 
translation of a few abundant proteins was decreased (like proteins 2-4), while others were 
unaffected (for instance number 1). The proteins were not experimentally characterized 
probably protein 1 was HSP70 and 2-4 were VSG, Aldolase and GAPDH because those 
proteins are very abundant in the cell and migrate at the corresponding sizes. This outcome 
ruled out the possibility that RBP10 was a general factor needed for translation, but it didn't 
reveal whether it acts on the level of translation or any other step of gene regulation such as 
RNA degradation.  
  
 
 
Fig. 8: SDS- gel autoradiogram showing the 35S labelled extracts of RBP10 knockdown cells -/+ tet. RNAi against RBP10 
was induced for 24h; after one hour in labeling medium the radioactively labelled 35S-methionine was added and 
incorporated into newly synthesised proteins. 
 
 
3.4 Effect of RBP10 RNAi on the BS transcriptome 
 
To examine the effect of RBP10 RNAi on the whole transcriptome, microarray analysis was 
used. RNA samples of BS cells depleted of RBP10 and of BS WT cells were reverse 
transcribed into cDNA using Cy3 or Cy5 labeled dCTP. The mixture of both RNA samples 
was hybridized onto an oligonucleotide microarray slide; after several washes the bound 
cDNA on the slide could be measured by excitation of the fluorophores.  5 slides including 3 
biological replicates and dye-swap were analyzed. Changes of a minimum of 1.5-fold with a 
p-value of ≤ 0.5 were considered to be significantly regulated.  
 
595 RNAs were affected by RBP10 RNAi: 275 increased and 320 decreased. The most 
striking changes in mRNA level were observed for genes involved in sugar metabolism and 
transport (Fig. 9 and supplementary Table S1). 21 mRNAs encoding glycosomal proteins or 
proteins involved in glucose metabolism, and also the major glucose transporter of the BS, 
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THT1, were decreased. Also broadly affected were genes encoding proteins of the flagellum 
and the cytoskeleton. A few of the obtained results were confirmed by Northern blotting (Fig. 
10 A-C). Additionally an increase of the mRNA encoding EP and a decrease of VSG mRNA 
could be seen after induction of RBP10 RNAi.  
 
 
 
Fig. 9 A-F: Effects of RBP10 RNAi and phloretin treatment on the BS transcriptome and of RBP10 expression on the PC 
transcriptome. Exponentially growing bloodstream-form trypanosomes (2x105/ml for BS RNAi and PC RBP10 expression; 
6x105/ml for phloretin treatment) were treated with 100 ng/ml tetracycline or 100 mM phloretin, respectively, for 24 h. 
Subsequently their RNA was prepared for microarray analysis using untreated cells as a control. The forced expression of 
RPB10 in PC was induced for 24 h with 100 ng/ml tet; the RNA was compared to PC WT cells.   
For each condition the results shown are for five slides including three biological replicates, including dye-swap, with all 
spots showing significant P ≤ 0.05 differences of at least 1.5-fold. The colour key is in the figure. 
A./B./C. Regulated RNAs of BS RBP10 RNAi/ phloretin / PC RBP10 expression classified according to regulation during 
differentiation, as seen in [15]. 
D./E./F. Regulated mRNAs of BS RBP10 RNAi/ phloretin / PC RBP10 expression  classified according to the function of the 
encoded protein [automated and manual annotation, as in [15]]. 
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Fig. 10 A-C: Northern blots showing the effect of RBP10 RNAi on different mRNAs. RNAi was induced for 24 h before 
RNA was extracted from exponentially growing cells. 7SL serves as loading control for quantification for each membrane. 
A: RBP10 RNAi sample was compared to RNA from uninduced RBP10 knockdown cells. The membrane was probed 
against the Tb927.3.4070 and the currently expressed VSG222. 
B: The RNA of RBP10 knockdown cells was compared to BS WT and PC WT RNA. The membrane was probed against 
Aquaporin and EP3-2.  
C: The RNA of BS WT cells was compared to RPB10 RNAi and phloretin treated cells. The membrane was probed against 
the 5’ end of the ORF of PGKC which recognizes the mRNA of all PGK isoforms. 
 
Several of the effects seen after RBP10 RNAi in the BS can also be seen after in the 
beginning of differentiation or after an inhibition of growth. To evaluate whether there was an 
overlap with the changes in the transcriptome seen during differentiation, I compared the 
results of RBP10 RNAi to the dataset of [15]. The methodology used in this analysis is very 
similar to mine and allows a quantitative comparison. The effect of inhibition of glucose 
uptake by phloretin also had certain similarities to the effect of RBP10 RNAi. Hence the 
effect of phloretin treatment on the transcriptome was evaluated (published in [23]) and 
compared to the effect of RBP10 RNAi. For an easier discussion I will use the “PC specific” 
to mean that an mRNA is more abundant in the PC than in the BS, but not that this according 
mRNA is only present in PC.   
320 mRNAs are decreased after RBP10 RNAi. Among them are 85 BS and only eight PC 
specific (Fig. 9D). The treatment with phloretin has a smaller effect with 153 mRNAs 
decreased. Some mRNAs also show a developmental regulation: 44 were BS and 13 PC 
specific (Fig. 9E). A subset of 71 mRNAs was decreased after both phloretin treatment and 
RBP10 RNAi. Here, 18 mRNAs encoding proteins of the glucose metabolism or glycosomal 
proteins and 16 mRNAs encoding proteins of the cytoskeleton or the flagellum could be 
found. This is most likely a result of a decline in growth which can also be seen in the 
beginning of differentiation where mRNAs encoding cytoskeletal and flagellar proteins are 
down-regulated [15].  
275 mRNAs increased after RBP10 RNAi (Fig. 9A). Of these, 84 were PC specific and 15 BS 
specific. In this group several mRNAs encoding mitochondrial and transmembrane proteins 
were found. The mRNA encoding the transporter PAD1, which is known to be increased in 
the stumpy form of the parasite [20], was also increased. This also accounts for the 
developmentally regulated phosphatase PIP39 (Tb10.70.4080) [21]. However, the increase of 
the mRNA under both conditions, RBP10 RNAi and phloretin, was lower than 1.5 fold and 
thereby filtered out. A total of 44 mRNAs were increased after phloretin treatment; 20 
mRNAs were PC- and 8 BS specific (Fig. 9E). Overall, 91 mRNAs were affected by both 
RBP10 RNAi and phloretin; the correlation coefficient within this subset is 0.9 
(Supplementary table 1). Thus this subset of mRNAs is affected very similarly under both 
conditions.  
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3.5 Expression of RBP10 induces BS specific mRNAs in PC 
 
RBP10 protein was not detectable in PC. I therefore investigated a possible effect of an 
ectopic expression of myc-tagged RBP10 in that stage. The RBP10 3’UTR has a length of ~8 
kilobases (kb), while the 3’UTR of the transgenic mRNA was only ~ 500 nucleotides short. 
Therefore the two transcripts could be distinguished by Nothern blotting (Fig. 11A). It could 
be seen that ectopic expression of RBP10-myc caused an increase in endogenous RBP10 
mRNA and protein (Fig. 11B). Moreover, a defect in proliferation (Fig. 11C) was seen; in 
several experiments the effect was ranging from growth arrest to cell death.  
 
 
Fig. 11: A. Nothern blot showing the forced expression of RPB10-myc in PC which can be detected at 1.5/1.8 kb. The 
endogenous RBP10 mRNA has a length of ~9kb. 7SL was used as loading control for quantification. B. Western blot 
showing the forced expression of RBP10-myc in the PC, the membrane was probed with the RBP10 antibody. Probing 
against Tubulin served as loading control. C. Cumulative growth curve of PC RBP10 expression. The figure legend is 
displayed below the graph.   
 
It was of interest whether the anomalous expression of RBP10 had an effect on the mRNAs 
that were affected by RBP10 RNAi in the BS. The BS specific THT1 mRNA was decreased to 
about 30% by RBP10 RNAi in BS trypanosomes (Fig. 12A). In PC WT cells, THT1 is hardly 
detectable by Northern blotting. Here, the ectopic expression of RBP10-myc raised the amont 
of THT1 to the abundance of the BS WT. THT2, which is normally higher expressed in the 
PC compared to the BS, decreased after the expression of RBP10 in PC (Fig. 12B). A similar 
effect could be seen for the developmentally regulated PGKB and PGKC mRNAs (Fig. 12C). 
Usually, BS trypanosomes express PCKC and display a higher level of PGKC than PCKB. In 
PC, PGKB is expressed and PGKB is more abundant than PGKC. The expression of RBP10 
in PC led to an increase of PCKC and a decrease in PCKB. However, the effect on THT1 was 
stronger than on the PGK mRNAs.  
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Fig. 12: Nothern blots showing the effect of the forced expression of RBP10 in PC on different mRNAs. Expression of 
RBP10 was induced with tetracycline 24 h before RNA was harvested. 7SL served as loading control for quantification. A. 
RNA of PC expressing RBP10 with a myc-tag at the N- or the C-terminus was compared to RNA of PC WT, BS WT and BS 
RBP10 RNAi. The membrane was probed against a specific region of the 3’UTR of THT1 [56]. B. PC RBP10 expression 
RNA was compared to RNA of PC WT, BS WT and BS RBP10 RNAi. The membrane was probed against THT2. C. RNA of 
PC expressing RBP10 bearing a myc-tag at the N- or the C-terminus was compared to RNA of PC WT and BS WT. The 
membrane was probed against the 5’ end of the PGKC ORF which is able to detect mRNAs of all PGK isoforms. 
 
To investigate the effect of RPB10 on the transcriptome, microarray analysis was used to 
compare RNA samples of PC WT with RNA of PC which expressed RBP10. It showed that 
the expression of RBP10 in PC had, in many ways, an opposite effect compared to RBP10 
RNAi in the BS. In total 346 mRNAs were changed (Fig. 9C), and again there was a 
correlation with developmental regulation (Fig. 9F). I could not only confirm the increase of 
the glucose transporter THT1, but also increases in mRNAs encoding for 5 proteins involved 
in glucose metabolism:  glucose-6-phosphate isomerase, glycerol kinase, ATP-dependent 
phosphofructokinase, fructose-bisphosphate aldolase and aquaglyceroporin. Additional 
mRNAs encoding glycosomal proteins were also increased but had a p-value higher than the 
cut-off. Several mRNAs that encoded for transporters and other transmembrane proteins were 
also increased (Fig. 9C and Supplementary table 1), indicating that the change in glucose 
transport was not the only effect on metabolite uptake. 
Of the 190 mRNAs that decreased during RBP10 expression, 79 were normally PC-specific, 
while none was BS-specific (Fig. 9F). A broad decrease of mRNAs encoding mitochondrial 
components (Fig. 9C) was the inverse of the increase seen during BS RNAi. There were 
seven mRNAs encoding glycosomal components, but three of them were not BS but PC 
specific. For HK2, which mRNA also was found to be decreased upon RBP10 expression, it 
was proposed that the protein might not have a hexokinase activity [78]. The decrease in 
mRNAs involved in protein synthesis was most likely a secondary effect of the growth 
inhibition. 
Since the expression of RBP10 in PC caused many effects in energy metabolism it was 
possible that the proliferation defect was due to an inability of the cells to generate energy 
from the sources present in the medium. Hence I tried to rescue the growth defect by adding 
4.6 g/l glucose to the medium. However, this had no effect (Fig. 11C). 
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3.6 Inhibition of differentiation by forced expression of RBP10 
 
Expression of RBP10 correlated with the expression of BS-specific transcripts.  Therefore it 
was interesting to know whether BS trypanosomes that constitutively express RBP10 would 
be able to differentiate into PC. I therefore transfected pleomorphic, differentiation-competent 
AnTat 1.1 cells with the RBP10 overexpression plasmid. RBP10 expression was induced with 
tetracycline 24 hours before I induced differentiation by adding cis-aconitate and decreasing 
the temperature to 27°C. Since RBP10 expression would kill PC, the medium was changed to 
MEM without tetracycline or cis-aconitate 24 hours later. The amount of RBP10 decreased 
during differentiation in the WT, while in the overexpression strain the endogenous protein 
level remained stable up to t24h (Fig. 13). After tetracycline removal both RBP10 proteins 
disappeared in the overexpression strain. As an indicator that the cells were transforming into 
PC the expression of EP procyclin was monitored. In the WT cell population, 24h after cis-
aconitate addition, EP procyclin expression had begun, though not to the full procyclin level, 
while RBP10 had decreased but was still detectable. It is nevertheless possible that RBP10 
and EP procyclin expression were mutually exclusive, since this was an asynchronous 
population, in which cells differentiated at varying rates [15]. Indeed, forced expression of 
RPB10 during the first 24h of differentiation completely prevented induction of EP procyclin. 
Moreover, the parasites overexpressing RBP10 died 1-3 days after the change of the medium 
even though tetracycline and RBP10 were absent. Again, addition of glucose to the procyclic 
medium didn’t rescue the parasites (data not shown).  
 
 
 
Fig. 13: Western blots showing the levels of EP, RBP10 and RBP10-myc of AnTat 1.1 cells during differentiation. Forced 
expression of RBP10-myc was induced 24 h before start of differentiation. Differentiation was performed as described by 
[15]. The membranes were probed with RBP10 and EP antibody. Staining of total protein with Ponceau S (P) served as 
loading control. 
Since PIP39 is known to be an important switch controlling differentiation [21] I used 
immunoprecipitation to look for an interaction between RBP10 and PTP1; no interaction was 
detected (data not shown).  
 
3.7 Can RBP10 override the effect of phloretin? 
 
The treatment of BS cells with phloretin is known to induce changes in RNA metabolism also 
seen in the beginning of differentiation [23]. In contrast to this it could be seen that the 
expression of RBP10 correlated with a BS phenotype. Therefore it was important to know if 
phloretin treatment has an effect on the expression of RPB10. I also wanted to investigate 
whether BS trypanosomes with a forced expression of RBP10 still respond to phloretin and 
start to express EP. After the addition of phloretin the cells grow very slowly due to the lack 
of available energy, I therefore induced the expression of RBP10-myc 24 h before phloretin 
treatment.  
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Fig. 14 A: Western blot showing the levels of RBP10 and RBP10-myc after treatment of phloretin with preceding induction 
of RBP10-myc forced expression. The membrane was probed with the RBP10 antibody. Detection of tubulin served as 
loading control. B: Northern blot showing the levels of THT1 and EP mRNA of the same cells as in 14A. 7SL mRNA was 
used as loading control for quantification. 
The expression of RBP10-myc was detected by Western blotting (Fig. 14A) using the RBP10 
antibody. After phloretin treatment it could be seen that the level RBP10-myc decreased 
slightly. This could be due to the reduced protein synthesis after phloretin treatment or due to 
other regulatory mechanisms. Phloretin is known to reduce the level of THT1 and increase the 
amount of EP in the BS. Fig. 14B shows a Northern blot with the levels of both mRNAs. It 
can be seen that in the WT the level of THT1 decreases after phloretin treatment. This was 
also the case for the BS RBP10 forced expression cells. Notably the overexpression strain 
showed a reduced level of THT1 even in the absence of phloretin. However, the results for EP 
mRNA were clear: Both BS WT and the RBP10 forced expression cell lines displayed a 
strong increase of EP, indicating that the treatment with phloretin was able to overrule RBP10 
expression.  
 
3.8 Direct mRNA targets of RBP10 
 
To address the question of possible direct mRNA targets of RBP10 the myc-tagged protein 
was expressed in the BS. After harvesting the cells, protein – DNA or RNA interactions were 
cross-linked by UV radiation, followed by the purification of the protein using myc-agarose. 
The bound proteins were degraded by a Proteinase K treatment, afterwards the RNA was 
extracted using Trifast FL (Peqlab). Aliquots of the total cell lysate, the flow-through and the 
eluate were collected for Western blotting. Fig. 15 shows the pull-down of RBP10-myc. 
There is a strong decrease in the level of RBP10-myc in the flow-through compared to the 
input, indicating that most of the tagged protein was bound to the beads.  
 
 
Fig. 15: Western blot showing the levels of RBP10 and RBP10-myc during the IP. The membrane was probed with the 
RBP10 antibody. Cell lysates of the input and flow-through corresponded to 3x106 cells, the eluate corresponds to 5x107 
cells. 
 
The isolated eluate RNA and the flow-through RNA, which was depleted of rRNA using the 
Ribominus kit (Invitrogen), were sent for deep-sequencing using the Illumina sequencing 
system. However, the sequencing results were ambiguous. There were only few reads for the 
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eluate, which might not be surprising and be explainable by the little amount of RNA found in 
the eluate. However, the number of average reads in the flow-through RNA was also quite 
low.  
Therefore I applied several filters: First all mRNAs with less than five reads were removed. 
The remaining mRNAs were sorted for a minimum of 2-fold increase in rpkm (reads per 
kilobase of gene length per million mapped reads) of the eluate compared to the flow-through 
for both the ORF and the 3’UTR. The result of this filtering can be seen in supplementary 
table 2. Several mRNAs encoding RBPs are enriched in the eluate, but also the mRNAs 
encoding for the large subunit of RNA polymerase IIA, PEX11, a component of the 
glycosomal membrane and an RNA helicase were increased.  
A comparison with the microarray datasets (Fig. 9) showed on overlap of 8 mRNAs which 
are also affected by RBP10 RNAi in the BS and 5 mRNAs that are changed after RBP10 
expression in the PC. Only one mRNA encoding a hypothetical protein was increased after 
RBP10 expression in the PC, decreased after RBP10 knockdown in the BS and enriched in 
the eluate of the RNA-IP. However, a knockdown by RNAi showed no effect in any life stage 
[79].  
 
3.9 Protein interaction partners 
 
The knockdown of RBP10 in the BS has strong effects on various mRNAs, but we could not 
find evidence for binding of those mRNAs by RBP10. It was shown that RRM motives can 
also function in protein-protein interactions [80]. Tandem Affinity Purification (TAP) was 
used as a first attempt to look for proteins interacting with RBP10 but could not reveal any 
specific interactions (data not shown). However, only distinct bands of the eluate were 
analysed by mass spectrometry. Potentially interacting, but less abundant proteins may have 
been missed. For this reason an immunoprecipitation was done; BS cells expressing RBP10-
myc and WT cells as control were lysed and incubated with myc-agarose beads. The binding 
of RBP10-myc to the beads worked well since most of the protein could be found not in the 
flow through but in the eluate as seen in Fig. 16A. As expected no protein can be detected by 
the RBP10 antibody in the WT eluate. Fig. 16B shows the image of the gel from which the 
samples were taken for mass spectrometry.  
Table 3 shows the identified proteins which potentially interact with RBP10 but which were 
not detected in the WT control. As expected, RBP10 itself could also be identified in the 
eluate of the RBP10-myc expression cell line.  
 
 
Fig. 16 A: Western blot showing the control for the IP of RBP10-myc. 4x108 cells of both RBP10-myc expression and WT 
were used. Lanes 1 and 2 correspond to 3x106 cells; in lane 5 ~5x107 cells equivalents are loaded. The membrane was probed 
with the RBP10 antibody. B: SDS gel analysed by mass spectrometry. For the analysis the lanes were divided into the 
specified sample.  
 
  3. Results 
 
22 
 
Table 3: Identified proteins potentially interacting with RBP10. Gray highlighted proteins are considered as false positives. 
“TAP” means that the proteins have previously been detected by Tandem-Affinity-Purification of RBP10-TAP. 
 
 
Grey highlighted proteins were considered as false positive candidates since they appear 
frequently in purifications of other proteins and are not known to be related to RBPs. One 
potential interaction partner, RBP29, has already been detected in the TAP. RBP29 was found 
to be on polysomes (Cornelia Klein, unpublished data). SCD6, which is a quite abundant 
protein in the cell and which is a part of P-bodies, was also found in other purifications, but 
since it is involved in RNA metabolism it is doubtful whether it should be considered as 
contaminant. Verifications of the interactions by reverse IP or by yeast-two-hybrid test are 
necessary for a reliable statement.  
None of the putative interaction partners are developmentally regulated as RBP10. There is 
also no change in the mRNAs encoding the proteins after BS RBP10 RNAi.  
 
3.10 Verification of RBP29-RBP10 interaction 
 
To verify a result of the mass spectrometry, a co-IP with RBP29 was done. RBP29, which 
was endogenously expressed with a V5 tag (cell line obtained from C. Klein), was 
immunoprecipitated using V5 agarose beads (Biomol). BS WT cells were used as controls. In 
total 2x108 cells were used for each experiment. Afterwards a sample of the input, the flow-
through and the whole eluate were analysed by Western blotting. The membrane was probed 
with the RBP10 and the V5 antibody.  
 
 
Fig. 17: Western blots showing the fractions of the Co-IP of RBP29-V5 and WT cell lysates. Input and flow-through 
correspond to 4.4x106 cells; the eluate corresponds to ~1.9x108 cells. The membrane was probed with A: RBP10 antibody 
and B: V5 antibody.  
Fig. 17A shows the pull-down of RBP29-V5 probed with the RBP10 antibody. Most likely 
the counting of the cells was imprecise, because more cells seem to be loaded for the WT 
control. However, a thin band can be detected for RBP10 in the eluate of the RBP29-V5 cell 
line. Also in the WT control this band can be seen, though it was weaker despite the uneven 
amount of cells used for the experiment. Fig. 17B shows the same membrane probed with the 
V5 antibody. It confirms that the pulldown of RBP29-V5 was successful. It could also be seen 
that most of the RBP29-V5 was bound to the beads since there was a decline of the RBP29-
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V5 signal in the flow-through compared to the input. This experiment confirms the binding of 
RBP10 to RBP29, though it could be that only a small portion of the proteins interact.  
 
3.11 Structural analysis of RBP10 
 
To gain insight in the important parts of the protein RBP10 I expressed four truncated 
versions (Fig. 18A) of RBP10 with a myc-tag at their C-terminus in the PC. Since RPB10 is 
normally not present in PC and the artificial expression of the full protein has a strong effect 
on several mRNAs like THT1 (Fig. 12A), the functionality of the different fragments could 
easily be measured by an observation of THT1. 
 
  
 
Fig. 18 A: Illustration of the five myc-tagged proteins expressed in PC: Full length RBP10 and the four shortened versions 
bearing deletions at either the C- and / or the N-terminus. B and C: Western blots showing the expression of the proteins in 
PC. The membranes were probed with the myc antibody (B) or RBP10 antibody (C). D: Northern blot showing the levels of 
THT1 in BS WT, PC WT and PC expressing the five proteins seen in 15A. 7SL served as loading control for quantification. 
 
 
The expression of the truncated proteins was verified by Western blotting using the myc 
antibody (Fig. 18B) and the RBP10 antibody (Fig. 18C). All the different fragments migrated 
at the expected sizes. Notably the expression of the fragment F3 was quite weak but could be 
detected by the RBP10 antibody, while F1 could only be detected by the myc- and not with 
the RBP10 antibody. The effect of the forced expression was measured by detection of the 
THT1 mRNA (Fig. 18D) and was normalized to the signal of the 7SL mRNA. The amount of 
THT1 is strongly inceased in PC expressing the full length RBP10 protein (labelled “RBP10”) 
compared to the PC WT and even to the BS WT. However, none of the truncated RBP10 
proteins caused an increase of the THT1 mRNA; instead the abundance of THT1 was in the 
same range as the PC WT.  
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3.12 Quantification of RBP10 in the BS 
 
To investigate the number of molecules of RBP10 per BS cell, various numbers of cells were 
compared to different amounts of recombinant protein. In Fig. 19 0.5x106, 2x106 and 4x106 
cells were compared to 50 ng and 100 ng of recombinant RBP10.  
 
 
Fig. 19: Western blot comparing different amounts of recombinant RBP10 with endogenous protein of BS cells. The 
membrane was probed with the RBP10 antibody. 
 
 
2x 106 and 4x 106 cells match with 50 ng and 100 ng of recombinant RBP10 protein, 
respectively. One molecule of RBP10 has a mass of 32.2 kDa, resulting in a rough estimate of 
4x105 RBP10 molecules per cell. This corresponds to 0.0004% of total cell protein, taking in 
account that 1.94x108 cells contain 1 mg of protein [81].  
 
3.13 Phosphorylation of RBP10 
 
RBP10 was found to be phosphorylated by [61] at the four serines S159, S161, S162 and 
S164. To confirm the phosphorylation and see whether it had an effect on the functionality of 
RBP10 I expressed five different mutated RBP10 proteins in the PC where a possible 
phosphorylation of the protein at the serine residues was abolished. Four proteins had a single 
mutation of one serine to glycine and one protein was bearing all four mutations (named 
“4xG”). The expression of the proteins in PC is shown in Fig. 20A. It can be seen that some 
of the different mutations influenced the migration of the proteins in the gel. S159G was 
detected above the other mutated proteins. The “WT” RPB10 protein was expressed with a 
myc-tag, therefore both the endogenous and the myc-tagged protein were seen here. For both 
clones of 4xG an additional band can slightly be seen, also a higher band can be detected at 
S162G C2. A possible impact of the mutations was measured by detection of the mRNA 
encoding the glucose transporter THT1. Normally this mRNA is decreased in the PC 
compared to the BS; the forced expression of RBP10 in the PC increased the amount of THT1 
(Fig. 12A). If the function of RBP10 was depended on phosphorylation, the mutated proteins 
would not increase the THT1 level and hence the amount of THT1 would be lower compared 
to PC expressing the normal RBP10.  
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Fig. 20 A: Western blot showing the expression of mutated RBP10 proteins in PC. The membrane was probed with the 
RBP10 antibody. The “RBP10” cells expressed the not mutated protein. “C1” stands for “clone1”, while “nsc” are cells not 
derived from a single clone.  B: Northern blot showing the levels of THT1 of different PC cell lines expressing the mutated or 
the not normal RBP10. 7SL served as loading control for quantification. 
 
Fig. 20B shows the THT1 levels of the PC expressing the regular RBP10 (“RBP10”) and the 
five different mutated versions, two different clones each. Generally the level of THT1 is very 
little in PC and the expression of RBP10 leads to a strong increase (Fig. 12) of THT1. 4xG C2 
displayed the same increase of THT1 as the not mutated protein; 4xG C1 showed a lower 
increase of THT1 which can be explained by the low expression seen by Western blotting 
(Fig. 20A). This indicates that the phosphorylation of RBP10 is not important for the 
functionality of RBP10 in the PC. Also both clones of S162G display a reduced increase of 
THT1.  
 
As seen in Fig. 13 AnTat 1.1 cells showed a double band recognized by the RBP10 antibody. 
This indeed could indicate a possible phosphorylation of the protein. However, the double 
band was not seen in all experiments and the conditions, under which the extra band was 
detectable, could not be clarified.  
To investigate whether RBP10 is phosphorylated in these cells a dephosphorylation assay was 
performed using the λ-phosphatase. The trypanosomes were lysed in the appropriate buffer 
for the enzyme and the supernatant was treated with the phosphatase for 20 min. Fig. 20C 
shows the assay with the AnTat 1.1 cells; for the control the cells were lysed directly in 
protein loading dye. “n.t.” means that the cells were lysed in the dephosphorylation buffer and 
frozen immediately after the addition of protein loading dye. In the control cells the double 
band could slightly be seen. Though in all samples that were lysed in phosphatase buffer no 
RBP10 was detectable any more. Even in the sample that was not incubated on ice for 20 min 
the protein was degraded. Hence the possible phosphorylation of RBP10 could not be 
confirmed.  
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Additional results 
 
3.14 Polysome gradient  
 
Cornelia Klein, a co-worker in the lab, ran a sucrose gradient with cell lysates of BS to 
investigate the protein composition on polysomes (Fig. 21A). I separated the obtained protein 
fractions by SDS-PAGE and analysed them by Western Blotting (Fig. 21B). It can be seen 
that RBP10 is mainly detectable in the fraction of the unbound proteins. Though, a minor part 
of the protein is associated with ribosomes and can be detected in the fractions from the 40S 
subunits up to trisomes. Also with a longer illumination of the ECL film RBP10 was not seen 
in the fractions of the heavy polysomes.  
 
Fig. 21 A: Polysome profile showing the absorbance at OD254 of the proteins in the different fractions of the gradient. B: 
Western blot of the proteins obtained from the sucrose gradient. The membrane was probed with the RBP10 antibody.  
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4. Discussion 
 
4.1 Effect of RBP10 
 
RBP10 was shown to be a BS specific protein (Fig. 4). In the PC the protein is not detectable, 
although RBP10 mRNA is still present at a low level (Fig. 11A). This makes it likely that the 
expression of RBP10 is regulated not only at the level of RNA stability but also affected by 
downstream events. The knockdown of RBP10 by RNAi (Fig. 4) resulted in an almost entire 
depletion of the protein and a severe defect in proliferation of the parasite (Fig. 5). The 
decrease of RBP10 was accompanied by strong changes in the transcriptome: The abundance 
of a large number of BS specific transcripts was decreased, while many PC specific mRNAs 
were increased after RBP10 RNAi. Using reporter constructs with 3’UTRs of two BS specific 
mRNAs, THT1 and PGKC 3’UTR, we could show that the regulation of RNA abundances 
occurred at posttranscriptional level via those 3’-UTRs (data from Beate Seliger). 
RBP10 RNAi affected the levels of many RNAs encoding proteins involved in glycolysis and 
the glucose transporter THT1. Though it is difficult to show that this affected protein levels, 
too, since there are no antibodies available against THT1. If RBP10 RNAi would have an 
effect on THT1 protein this could already be sufficient to explain the lethality of the 
knockdown. The reduction of glucose uptake would lead to a decrease of the glycolytic flux 
since the glucose transporter has a strong flux control coefficient [70]. A reduction of the flux 
of 30-50% as a consequence of glucose uptake inhibition is sufficient to block growth [23], a 
stronger inhibition of glycolysis leads to cell death. In this study was also shown that a 
decrease of intracellular glucose does not lead to a higher expression of the glycolytic 
components, but in the contrary to an even stronger down regulation of the glucose transporter 
and the glycolytic enzymes. This effect could also be seen after RBP10 knockdown: most 
mRNAs encoding for glycolytic enzymes were decreased in a very similar way as after 
phloretin treatment. There were 91 transcripts affected under both conditions with a 
correlation coefficient of 0.9 including several of those transcripts mentioned (supplementary 
table 1).  
An inhibition of glucose uptake also leads to a partial differentiation [23]: several BS specific 
mRNAs are decreased and PC specific transcripts are increased. This can be seen after RBP10 
RNAi, too. However, the overlap between phloretin treatment and RBP10 knockdown is not 
large enough to say that the two conditions are the same and claim that the whole effect of 
RBP10 RNAi can be reduced to the inhibition of glucose uptake. RBP10 RNAi has a much 
more widespread effect on the transcriptome than phloretin treatment. A more severe 
inhibition of proliferation is unlikely to be the reason for the broader effect of RBP10 RNAi 
since the decline in growth was not stronger than after treatment with phloretin. The inhibition 
of growth is also displayed in the transcriptome under both conditions: several mRNAs 
encoding for proteins of the cytoskeleton and the flagellum are decreased, some of these 
transcripts are also part of the 91 mRNAs whose regulation overlap between RBP10 RNAi 
and phloretin. Nevertheless, it is unclear to which extent the growth defect has affected the 
microarray results. Knockdowns of many proteins lead to a defect in growth, but not all 
induce the expression of EP. The inhibition of growth by the reduction of glucose uptake 
evokes an increase of EP and other PC specific mRNAs [23]. RNAi against the RNA helicase 
DHH1 has an effect on developmentally regulated mRNAs [82].  However, DHH1 is assumed 
to be involved in a pathway to regulate many stage specific mRNAs. Therefore this effect 
would not be related to a growth defect. On the other hand, the knockdown of UBP1 or UBP2 
also results in a defect in proliferation but has no effect on EP [53], same as RNAi against 
ZC3H11 (Droll et al, unpublished). Eventually this could mean that either there are different 
kinds of growth defects in the BS and only some induce the expression of PC specific 
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mRNAs; or each growth inhibition leads to the expression of mRNAs like EP but under some 
conditions, for example after a knockdown of a specific protein, the cells are not able any 
more to start the expression.  
 
The changes in the transcriptome caused by the expression of RBP10 in the PC indicate that 
the developmental regulations are not only due to growth arrest. PC expressing RBP10 
showed almost the opposite effect in comparison to BS RBP10 RNAi. The expression of 
RBP10 in PC displayed an even stronger correlation to developmental regulation. Large 
portions of the increased mRNAs were BS specific, while several of the decreased mRNAs 
were PC specific. Among the increased mRNAs was also the BS specific RBP10 followed by 
the expression of RBP10 protein (Fig. 11B). If RBP10 would only control the glucose 
transporter THT1 and the glycolysis, one could speculate that with the expression of RBP10 
in PC the defect in proliferation could be rescued by the addition of glucose to the medium. 
This was however not the case. Though, also in the PC the expression of RBP10 came along 
with a BS phenotype. This raised the question whether fully differentiation competent AnTat 
1.1 cells were still able to undergo differentiation if expression of RBP10 was constantly 
forced. As seen in Fig. 13 this was not the case, the cells died and showed no expression of 
EP. Since the forced expression of RBP10 was induced only in the first 24 hours it can be 
excluded that the cells first differentiated into PC and died afterwards, but the precise 
mechanism how the differentiation was inhibited is not known.  
Normally differentiation is triggered by the PAD transporters, which are localized on the cell 
surface of stumpy form parasites and sense cis-aconitate [20]. The tyrosine phosphatase PTP1 
is responsible for maintenance of the stumpy form until the start of differentiation [62]. PTP1 
prevents differentiation by dephosphorylating another phosphatase, PIP39, whose presence is 
required for differentiation [21]. Both PTP1 and RBP10 are necessary for the maintenance of 
the BS state. Since RRM motifs can function in protein-protein interactions [80], an 
interaction between the two proteins might have been possible. However, no such interaction 
was detected by immunoprecipitation.  
 
Glucose starvation is also able to induce at least partial differentiation as seen in [23]. A full, 
but slower differentiation by removal of glucose from the medium is possible [22]. The 
expression of RBP10 was shown to be sufficient for the expression of many BS specific 
mRNAs. There is a weak decline of RBP10 protein after treatment with phloretin (Fig. 14). 
Even with an additional expression of RBP10-myc, phloretin treatment was able to override 
the expression of RBP10 and induce the expression of EP (Fig. 14). This leads to the 
conclusion that there could be two different pathways to start differentiation. A differentiation 
by cis-aconitate was shown to be inhibited by the artificial expression of RBP10-myc, while 
differentiation via glucose uptake inhibition was unaffected by RBP10 expression. One could 
speculate the two routes are independent pathways to induce differentiation.  
 
4.2 Functionality of RBP10 
 
RBP10 was found to be localized to the cytosol by immunofluorescence and subcellular 
fractionation (Fig. 6 and Fig. 7). This makes it unlikely that RBP10 is involved in processes 
like pre-mRNA processing, which takes place in the nucleus. Rather, it would be probable 
that RBP10 binds to, and stabilizes, BS specific transcripts. However, this cannot be 
confirmed since the transcripts that were seen to be affected by RBP10 RNAi in the BS or 
RBP10 expression in the PC could not be found enriched in the eluate of the RNA IP. After 
filtering the putative direct mRNA targets 90 mRNAs remained (supplementary table 2). The 
filtering leads to a small bias for long mRNAs since all transcripts with less than 5 reads in 
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the ORF in the eluate and the flow-through were removed. This was necessary because even 
in the flow-through there was a poor coverage of reads alignment. This raises the question 
whether the RNA used had a low quality and maybe was mostly degraded or whether the 
sequencing itself worked as designed.  
Most of the putative mRNA targets which showed at least 2-fold increases in the eluate 
compared to the flow-through were diverse and could not be clustered. However, there were 
three mRNAs encoding proteins involved in glucose metabolism (PEX11, fructose-
bisphosphate aldolase and glycosomal phosphoenolpyruvate carboxykinase). These mRNAs 
were not affected by RBP10 RNAi which questions the reliability of this outcome. If RBP10 
would stabilize those mRNAs one would expect it to be on polysomes. RBP10 was not found 
in the heavy polysome fractions (Fig. 21), which excludes a constant binding to the mRNAs 
during translation. Most of the protein was detected in the fraction of the free proteins. This 
confirms the results of the glycerol gradient (work of Valentin Färber) which showed that 
most RBP10 protein is not involved in large complexes (data not shown).  
However, in the sucrose gradient the signal of RBP10 was detectable in the fractions from the 
free proteins to the fractions of the trisomes, which could mean that RBP10 transiently binds 
to mRNAs and can be found in a complex with ribosomes, but dissociates after translation 
initiation or after the first round of translation.  
 
Immunoprecipitation of RBP10-myc revealed several potential interaction partners (Table 3). 
Besides PABP2, three of these potential interaction partners have been shown to be involved 
in RNA metabolism. The U2 splicing auxiliary factor seems to be an unlikely interaction 
partner since splicing takes place in the nucleus. This nevertheless could be a valid interaction 
if RBP10 would, under certain stress conditions, shuttle to the nucleus as seen for UBP1 after 
arsenite treatment [83]. Shuttling to the nucleus has also been shown for PABP2. Inhibition of 
transcription, but not arsenite stress, leads to migration of PABP2 to the nucleus. However, 
the role of PABP2 is not clear yet. Its homologue in L.major has a weak affinity to Poly-A 
and binds to the translation initiation factor LmEIF4G3 only in vitro and not in vivo. It was 
suggested that the protein either acts as a general factor for RBPs in posttranscriptional 
control or for it could be associated with mRNA export.   
Another identified protein which is associated with RNA is SCD6, which is known to be a 
marker for P-bodies. P-bodies are proposed to be the sites of RNA decay and SCD6 thereby a 
possible interaction partner. On the other hand SCD6 is quite abundant and could also be a 
false positive like many chaperones. Immunofluorescence to look for an overlap of RBP10 
and SCD6 could show colocolization; a reverse IP or a yeast-2-hybrid experiment could 
confirm the interaction. 
Another protein potentially interacting with RBP10 was RBP29, which also was found to be 
associated with polysomes (Klein et al, unpublished). Knockdown of RBP29 is lethal in the 
BS [79]. The interaction of RBP10 and RBP29 was confirmed by pulldown of RBP29 and 
subsequent detection of RBP10 in the eluate (Fig. 17), though only a minor part of the 
proteins are interacting. It can be speculated that the contact of the two proteins takes place on 
mRNPs (ribonucleoproteins). If this would be the case a stronger interaction might be 
detectable if the IP was performed in the presence of RNAse inhibitors. 
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4.3 Structural analysis of RBP10 
 
RBP10 protein is normally not expressed in PC but its forced expression evokes changes in 
several mRNAs like THT1. This gave the possibility to investigate which parts of RBP10 
were necessary and also to study a possible role of phosphorylation of the protein. For the 
structural analysis, four different truncated versions of RBP10 were expressed in PC, none of 
them showed an increase in THT1 mRNA. This could be due to improper folding of the 
fragments; this could only be confirmed by X-ray crystallography. It is also possible that 
indeed the whole protein is necessary for its functionality though the only know motif of 
RBP10 is the RRM.  
Also the phosphorylation seen in the phosphoproteome [61] was studied first in PC by 
expressing proteins with mutation at the serine residues 159,161,162 and 164. Especially the 
expression of the RBP10 with all four serines exchanged was expected to show no effect on 
THT1 in PC if the phosphorylation was crucial for its function. However, most of the 
investigated clones in Fig. 12A showed the same effect as RBP10. This indicates that the 
phosphorylation is not important in terms of the function of RBP10. However, in most 
Western blots with PC or BS trypanosomes only a single band was detectable. An extra band 
for RBP10 was seen occasionally in AnTat 1.1 cells (Fig. 13) and even less often in 
monomorphic BS. To investigate a possible phosporylation in BS, I performed a 
dephosphorylation assay using the λ-phosphatase. However, RBP10 was extremely unstable 
in the buffer used for the assay because even without phosphatase treatment and incubation 
the protein was degraded after lysis of the cells. Another way to examine a possible 
phosphorylation in BS would be to knock down the endogenous RBP10 by RNAi targeting 
the 3’UTR of RBP10 and simultaneously express the mutated versions of the protein.  
 
4.4 Future perspectives 
 
In this work I could show the effect of RBP10 expression and depletion in T.brucei. For a 
better understanding how the regulations are achieved several experiments could be done. The 
search for direct mRNA target revealed some candidates. Although these mRNAs are not 
affected by RBP10 RNAi in the BS, they could be valid targets and the results of the 
microarray studies a subsequent regulation. A direct interaction between RBP10 and an 
mRNA target could be confirmed by RNA-IP with a following semi-quantitative RT-PCR or 
quantitative RT-PCR. If the outcome would be negative it would be important to investigate 
whether RBP10 binds to RNA at all using the PAR-CLIP method (Photoactivatable-
Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) [84]. This would need a 
preceding setup of the used system in T. brucei. If this result would show that RBP10 actually 
binds to RNA, a repetition of the deep-sequencing of the bound RNA should be done since it 
is possible that the first sequencing did not work as designed.  
Several protein interaction partners for RBP10 were found by IP and the binding to RBP29 
was confirmed. The Co-IP with RBP29 could be repeated in the presence of RNAse inhibitors 
to see whether the interaction is RNA dependent. For the remaining potential interaction 
partners a reverse IP would be necessary to show the specificity of the interactions. This could 
clarify in which pathway RBP10 is involved in. PABP2, which is known to shuttle to the 
nucleus under transcription inhibition, was also detected as potential interaction partner. 
Therefore a possible change in the localization of RBP10 under different stress conditions like 
block of transcription or arsenite addition could be investigated. 
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